Additional Metadata
Persistent URL hdl.handle.net/1765/110823
Journal Anti-Cancer Drugs
Citation
Franken, M.-C, Kanters, T.A, Coenen, J.L., De Jong, P., Koene, H., Lugtenburg, P.J, … Uyl-de Groot, C.A. (2018). Potential cost savings due the route of administration of oncology drugs: A micro-costing study of intravenous and subcutaneous administration of trastuzumab and rituximab in The Netherlands. Anti-Cancer Drugs, 29, 791–801. Retrieved from http://hdl.handle.net/1765/110823